Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

Bausch + Lomb Announces Launch of New Soothe® XP Eye Drops with Restoryl® Mineral Oils

Product Targets Dry Eye Symptoms at their Source 


BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced the availability of Soothe® Xtra Protection (XP) eye drops with Restoryl®, a unique emulsion system featuring a proprietary blend of mineral oils and interfacial molecules. The eye drops target the main source of dry eye symptoms by replenishing the lipid layer of the tear film. 

“By restoring lipid layer thickness, Soothe XP with Restoryl addresses a key component in the onset of dry eye symptoms.  We are pleased to bring back the product to eye care professionals and consumers,” said Cal Roberts, M.D., chief medical officer, Bausch + Lomb. “Bausch + Lomb’s mission continues to help patients see better to live better, and we are excited to offer a product that goes further than most other dry eye drops on the market to address the most common cause of dry eye symptoms.”

A compromised lipid layer of the tear film, which results in tear evaporation, is the deficiency most commonly associated with dry eye symptoms.1-4 The product on shelf is now preserved with polyquaternium-1 (PQ1) and has a borate buffer system - both are widely used in in ophthalmic formulations.

"I am most happy to once again have Soothe  XP available for the care of my patients,” said Randall Thomas O.D., MPH. “This was the flagship lipid-based artificial tear, and one that my patients found highly effective in helping to relieve their dry eye symptoms.  My patients are thrilled to have Soothe XP available to them again."

Soothe XP is now available at Walmart and will be available in Target in July. Additional retailers, such as Walgreens, Rite Aid and CVS, will follow in the coming months. 

About Bausch + Lomb:
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.

1. Foulks, GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol.2007;52(4):369:374. 
2. Blackie CA et al. The Relationship Between Dry Eye Symptoms and Lipid Layer Thickness. Cornea 2009;28:789–794. 
3. Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optom Vis Sci. 2000;77:357-63. 
4. Lemp MA et al. Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient Cohort: A Retrospective Study. Cornea. 2012;31:472–478.

Soothe and Restoryl are trademarks of Bausch & Lomb Incorporated or its affiliates. 
All other product/brand names are trademarks of their respective owners.

News Media Contacts:
Kristy Guerra
Public Relations Product Manager, Bausch + Lomb
(585) 338-8095 or

Don Murphy
Zeno Group, on behalf of Bausch + Lomb
(212) 299-8970 or


Actions: E-mail | Permalink |